Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Evonik and Genedata broaden their collaboration with the Genedata Selector biotechnology data management platform

Published: Sunday, September 22, 2013
Last Updated: Saturday, September 21, 2013
Bookmark and Share
Genomic strain data management solution supports Evonik growth in biotechnology

Genedata, a leading provider of advanced software solutions for industrial, agricultural, drug discovery, and life science research, has announced that Evonik is extending its collaboration with Genedata. Building on its long-standing partnership with Genedata, Evonik is using the Genedata fully integrated offering that includes Genedata Selector™ for the management and analysis of strain information, scientific data analysis consulting provided by Genedata bioinformatics experts, and specialized IT services. The integrated solution from Genedata will help Evonik advance its industry diversification projects and strengthen the return on its strategic biotechnology investments.
"New, data-intensive and omics-based technologies are catalysts for innovation in the health and food industries," noted Dr. Ralf Kelle, vice president of R&D Bioproducts for the Evonik Health and Nutrition business unit. "Genedata - with its domain expertise in data analysis and management - helps us get maximum value from our data. More importantly, our relationship with Genedata allows us to benefit from their innovative solutions, which contribute to the success of our resource-efficient and sustainable biotechnology research."
Beyond Software - Scientific Data Analysis Consulting & Specialized IT Services

Evonik has successfully used Genedata Selector to manage, visualize, and analyze complete genomes of production strain collections with a focus on mutation analysis and deciphering complex genotype-phenotype relationships. Genedata Selector accelerates difficult strain optimization projects for the production of bio-based chemicals, nutritional proteins, food and feed additives, and cosmetics ingredients.
Now, in addition to Genedata Selector enterprise software, Evonik will also use Genedata scientific data analysis consulting services. Based on in-depth and extensive experience in the industrial biotechnology field, these value-added services help to eliminate resource bottlenecks, provide cost-effective support for strategically important projects, and deliver valuable results quickly and efficiently.
Addressing the complete life cycle of R&D projects - from early-stage feasibility studies to late-stage product development - Genedata scientific data analysis consulting delivers:
proprietary genome annotations, including gene calling and functional annotations up to the pathway level (for prokaryotes as well as eukaryotes);
production strain comparisons, including interpretations of biological effects of variants (e.g. on enzyme activities);
cellular signaling network reconstructions for proprietary strains, based on expression and regulatory sequence data;
biomarkers, based on omics, NGS, pathway, and functional annotation data; and
statistical expression analysis reports (e.g. of microarray or RNAseq data). 

In the enterprise R&D environment, Genedata specialized IT services ensure server availability and infrastructure stability for high-performance server infrastructures. These services, which empower researchers to focus more on scientific discovery, include:
hosting and remote server maintenance;
software and database integration services; and
data migration and integration services, including public domain genome release monitoring.

"We are proud of our long-standing and successful partnership with Evonik, a world leader in specialty chemicals," noted Dr. Othmar Pfannes, CEO of Genedata. "Their adoption of the Genedata Selector application suite, coupled with our scientific consulting and professional IT services, serves as an industry model for other customers in industrial biotechnology research who want to leverage the full advantage of our bioinformatics expertise to achieve their business objectives."

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Genedata Completes Important Milestone in Collaboration with Bayer Pharma AG
Successful integration of Genedata Profiler™ allows researchers to access, process, analyze and manage petabytes of NGS and other omics data from patients and pre-clinical experiments.
Thursday, September 24, 2015
Merck Serono Chooses Genedata Biologics to Streamline Antibody Discovery Processes
Global deployment of Genedata Biologics across multiple protein therapeutics R&D groups to standardize workflows and improve efficiency.
Thursday, July 23, 2015
Genedata Releases a Breakthrough for Genomic Comparison
Genedata Selector™4.0 provides reference-independent genome sequence comparisons while reducing data processing and analysis time to optimize efficiency and save costs.
Wednesday, July 22, 2015
Genedata Forges Alliance with Intellicyt
Swiss informatics firm Genedata and Intellicyt today announced an alliance to work on cell-based screening in drug discovery.
Thursday, June 18, 2015
Precision Medicine Software Genedata Profiler™ Launched at Bio-IT World
Open, interoperable enterprise platform for patient and compound profiling provides important data management infrastructure for pharma internal R&D processes.
Friday, April 24, 2015
Partner on Innovative Workflow Platform for High-Throughput Cell Line Development
Novel Cell Line Development (CLD) data platform to support the generation and assessment of mammalian production cell lines.
Tuesday, March 17, 2015
Genedata, Bayer Pharma AG Partner on Innovative Workflow Platform for High-Throughput Cell Line Development
Novel Cell Line Development (CLD) data platform to support the generation and assessment of mammalian production cell lines.
Tuesday, March 17, 2015
Genedata Biologics Licensed by Pfizer
Pfizer implements Genedata Biologics to streamline global biopharma R&D processes.
Wednesday, March 04, 2015
Boehringer Ingelheim Selects Genedata Biologics as Antibody Discovery Workflow Platform
Genedata Biologics integrates and streamlines workflows for protein therapeutics R&D groups across multiple Boehringer Ingelheim sites.
Thursday, February 19, 2015
Exploring Innovations in SPR & Combination Screening
Genedata customers will discuss innovations in high content imaging, high throughput screening, compound combination screening, and other related topics at User Group Meetings.
Tuesday, August 26, 2014
GSK Implements Genedata Biologics as Antibody Discovery Platform
Genedata Biologics integrates GlaxoSmithKline's Biopharm Discovery workflows across multiple Biopharm R&D groups and sites
Thursday, June 12, 2014
Genedata Showcases Integrated Analysis & Image Management Solution for Phenotypic Screening
Regardless of instrument or application, Genedata Screener® for High Content Screening enables time-efficient workflow for analysis of high-content experiments
Friday, February 21, 2014
Genedata Announces New Data Analysis Platform for Next-Gen Oncology Drug Discovery
AstraZeneca and Genedata detail a data analysis platform for compound combination experiments in oncology and other therapeutic areas
Monday, February 03, 2014
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology Chooses Genedata Expressionist for Oncology Research
Leading clinical-research institute of the Robert Bosch Stiftung uses Genedata Expressionist for managing, processing, and interpreting clinical NGS data
Monday, January 27, 2014
Biogas Consortium Using Genedata Selector for Metagenomics-based Process Optimization
Genedata Selector platform to manage, analyze, and integrate complex microbial genomes and strains will be showcased in 5th Annual NGS Conference Poster Session
Saturday, November 23, 2013
Scientific News
Scientists Create World’s Largest Catalog of Human Genomic Variation
An international team of scientists from the 1000 Genomes Project Consortium has created the world’s largest catalog of genomic differences among humans, providing researchers with powerful clues to help them establish why some people are susceptible to various diseases.
New Autism Genes Are Revealed in Largest-Ever Study
Work draws more detailed picture of genetic risk, sheds light on sex differences in diagnosis.
Influenza A Viruses More Likely To Emerge In East Asia Than North America
Novel strains of influenza A are more likely to emerge in East Asia than in North America, according to a global analysis by the One Health Institute at the UC Davis School of Veterinary Medicine and EcoHealth Alliance.
Bone Risks Linked to Genetic Variants
A large-scale genomic study uncovered novel genetic variants and led researchers to an unexpected gene that affects bone density and fracture risk.
The Final Word on STAP
Researchers fail to replicate STAP study; computational analysis reveals genomic inconsistency.
Study Adds to Evidence That Viruses Are Alive
A new analysis supports the hypothesis that viruses are living entities that share a long evolutionary history with cells, researchers report.
CSI -- On The Metabolite's Trail
Bioinformaticians at the University of Jena make the most efficient search engine for molecular structures available online.
Potential Ovarian Cancer Biomarker Isolated
Researchers from North Carolina State University utilized a highly sensitive mass spectrometry analysis to identify and measure difficult-to-detect N-glycan biomarkers associated with ovarian cancers in stages I – IV.
Smartphone App to Monitor Serious Blood Disorder
A researcher from Florida Atlantic University has come up with a unique way to monitor sickle cell disease -- a serious blood disorder -- using a smart phone.
Network Control: Letting Noise Lead The Way
Research team leverage cells' noisy nature to keep them healthy.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos